{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:12:28Z","timestamp":1774296748596,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"15-16","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.vaccine.2003.11.014","type":"journal-article","created":{"date-parts":[[2003,12,9]],"date-time":"2003-12-09T11:55:53Z","timestamp":1070970953000},"page":"1930-1940","source":"Crossref","is-referenced-by-count":51,"title":["Immunization with the hybrid protein vaccine, consisting of Leishmania major cysteine proteinases Type I (CPB) and Type II (CPA), partially protects against leishmaniasis"],"prefix":"10.1016","volume":"22","author":[{"given":"Azita","family":"Zadeh-Vakili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahere","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasaman","family":"Taslimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Doustdari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali-Hatef","family":"Salmanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sima","family":"Rafati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2003.11.014_BIB1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB2","unstructured":"Herwaldt B. Leishmaniasis. In: Fauci A, Braunwald E, Isselbacher KJ, editors. Harrison\u2019s principles of internal medicine. New York: McGraw-Hill, 1998. p. 1189."},{"issue":"7","key":"10.1016\/j.vaccine.2003.11.014_BIB3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.186.7.1137","article-title":"Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major","volume":"186","author":"Gurunathan","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1089\/hum.1998.9.13-1899","article-title":"Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis","volume":"9","author":"Walker","year":"1998","journal-title":"Hum. Gene. Ther."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB5","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1128\/IAI.63.11.4261-4267.1995","article-title":"Protective vaccination with promastigote surface antigen 2 for Leishmania major is mediated by a TH1 type of immune response","volume":"63","author":"Handman","year":"1995","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB6","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.157.11.5034","article-title":"Molecular cloning of a novel protein antigen of Leishmania major that elicits a potent immune response in experimental murine leishmaniasis","volume":"157","author":"Webb","year":"1996","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.vaccine.2003.11.014_BIB7","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB8","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0264-410X(99)00340-0","article-title":"The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis","volume":"18","author":"Solioz","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1389202033490439","article-title":"Leishmania cysteine proteinases: from gene to subunit vaccine","volume":"4","author":"Rafati","year":"2003","journal-title":"Curr. Genom."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB10","doi-asserted-by":"crossref","unstructured":"Robertson CD, Coombs GH, North MJ, Mottram JC. Parasite cysteine proteinases. In: Mckerrow JH, James MNG, editors. Cysteine proteinases, vol. 6. ESCOM Science Publisher, 1996. p. 99.","DOI":"10.1007\/BF02174048"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/eji.1830250435","article-title":"Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigotes cysteine proteinases requires intracellular killing of the parasites","volume":"25","author":"Wolfram","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB12","unstructured":"Coombs GH, Robertson CD, Mottram JC. Cysteine proteinases of leishmaniasis. In: Proteinases of trypanosomes and leishmania: biology and control. Oxford: CBA International, 1997. p. 209."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB13","first-page":"133","article-title":"Evaluation of cellular immune responses to amastigote soluble Leishmania major antigens in recovered cases of cutaneous leishmaniasis","volume":"11","author":"Rafati","year":"1997","journal-title":"Med. J. Islamic Repub. Iran"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-6851(00)00377-7","article-title":"Identification of Leishmania major cysteine proteinases as target of the immune response in humans","volume":"113","author":"Rafati","year":"2001","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB15","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/S0264-410X(02)00189-5","article-title":"Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB\/c mice: the partial protection relies on interferon gamma producing CD8+ T lymphocytes activation","volume":"20","author":"Rafati","year":"2002","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2003.11.014_BIB16","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/S0264-410X(01)00081-0","article-title":"A protective cocktail vaccine against murine cutaneous leishmaniasis with DNA encoding cysteine proteinases of Leishmania major","volume":"19","author":"Rafati","year":"2001","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.014_BIB17","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/00029330-200804020-00006","article-title":"A recombinant multi-epitope, multi-stage malaria vaccine candidate expressed in Escherichia coli","volume":"112","author":"Li","year":"1999","journal-title":"Chin. Med. J."},{"issue":"10","key":"10.1016\/j.vaccine.2003.11.014_BIB18","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1128\/IAI.68.10.5839-5845.2000","article-title":"Genetic immunization of BALB\/c mice with a plasmid bearing the gene coding for a hybrid merozoite surface protein 1-hepatitis virus surface protein fusion protects mice against lethal plasmodium chabaudi chabaudi PC1 infection","volume":"68","author":"Wunderlich","year":"2000","journal-title":"Infect. Immun."},{"issue":"8","key":"10.1016\/j.vaccine.2003.11.014_BIB19","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/IAI.70.8.4215-4225.2002","article-title":"Immunization with a polyprotein vaccine consisting of T-cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein, and Leishmania elongation initiation factor protects against Leishmaniasis","volume":"70","author":"Coler","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/expr.1996.4116","article-title":"Leishmania major: comparison of the cathepsin L- and B-like cysteine proteinase gene with those of other trypanosomatids","volume":"85","author":"Sakanari","year":"1997","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB21","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"Laemmli","year":"1970","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/expr.1996.4137","article-title":"Leishmania major: molecular cloning, sequencing and expression of the heat shock protein 60 gene reveals unique carboxy terminal peptide sequences","volume":"85","author":"Rey-Ladino","year":"1997","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.vaccine.2003.11.014_BIB23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0014-5793(92)80309-5","article-title":"Immidazole-SDS-Zn reverse staining of proteins in gels containing or not SDS and microsequence of individual unmodified electroblotted proteins","volume":"296","author":"Ortiz","year":"1992","journal-title":"FEBS"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1574-6968.1992.tb14070.x","article-title":"On the post-translational modifications at the C-terminal domain of the major cysteine proteinase from Trypanosoma cruzi","volume":"79","author":"Cazzulo","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB25","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.4049\/jimmunol.161.12.6794","article-title":"Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response","volume":"161","author":"Alexander","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1369-5274(98)80065-9","article-title":"Roles of cysteine proteinases of Leishmania in host\u2013parasite interaction","volume":"1","author":"Mottram","year":"1998","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.170.4.1746","article-title":"The Leishmania mexicana Cysteine Proteinase CPB2.8, induces potent Th2 responses","volume":"170","author":"Pollock","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB28","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.1365-2249.2000.01160.x","article-title":"Vaccination of BALB\/c mice with Leishmania major amastigote-specific Cysteine Proteinase","volume":"120","author":"Rafati","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB29","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/IAI.65.6.2052-2059.1997","article-title":"Characterization of an antigen from Leishmania amazonensis amastigotes able to elicit protective responses in a murine model","volume":"65","author":"Beyrodt","year":"1997","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB30","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/IAI.69.6.4103-4108.2001","article-title":"Protection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models","volume":"69","author":"Campos-Neto","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB31","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0264-410X(98)00363-6","article-title":"Long-term protection of mice against Leishmania major with a synthetic peptide vaccine","volume":"17","author":"Spitzer","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2003.11.014_BIB32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-2249.1997.tb08318.x","article-title":"Biochemical analysis and immunogenicity of Leishmania major amastigote fractions in cutaneous leishmaniasis","volume":"110","author":"Rafati","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.vaccine.2003.11.014_BIB33","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1128\/IAI.71.5.2924-2926.2003","article-title":"TH1 cell development towards cysteine proteinases A and B in localized cutaneous leishmaniasis due to L. guyanensis","volume":"71","author":"Pascalis","year":"2003","journal-title":"Infect. Immunol."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X03008053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T16:16:51Z","timestamp":1682612211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X03008053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":33,"journal-issue":{"issue":"15-16","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0264410X03008053"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2003.11.014","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}